Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Advanced Multidisciplinary Research for Antimicrobial Resistance

Project description

Long-term research to combat antimicrobial resistance

Antimicrobial resistance (AMR) poses a grave threat to global public health, with the World Health Organization ranking it among the top 10 global challenges. The ongoing COVID-19 pandemic has further underscored the urgency to address this as it amplifies the risk of resistance due to increased antimicrobial drug usage. With the support of the Marie Skłodowska-Curie Actions programme, the AMRAMR project aims to foster long-term research cooperation, focusing on developing innovative antibacterial nanomaterials, thin-film coatings, upconversion and photonics technologies, and assessing antibacterial performance to combat AMR. Spanning 4 years, this collaborative effort involves industry and academic institutions in Europe, China, and the United States.

Objective

We are proposing a 4-year program of knowledge transfer and networking between academic institutions [University of Leicester (UK), University of Valencia (Spain), International Iberian Nanotechnology Lab (Portugal), University of Bologna (Italy), University of Aveiro (Portugal), Fudan University (China), and Alfred University (USA)] and industrial partners [Teer Coatings Ltd (UK)]. The objective of the proposed joint exchange programme is to establish long-term stable research cooperation between the partners with interdisciplinary expertise and knowledge to develop Advanced Multidisciplinary Research for Antimicrobial Resistance (AMRAMR), including the development of novel antibacterial nanomaterials and nanostructures, novel antibacterial thin films coatings, upconversion technology for AMR applications, photonics technology for AMR application, and evaluation of the antibacterial performance and antimicrobial resistance; the synergetic effect for the above approaches to understanding antimicrobial resistance.

Antimicrobial resistance (AMR) refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of antimicrobial drugs, such as antibiotics, antivirals, antifungals, and antiparasitics. AMR is a serious global public health threat that could lead to increased morbidity, mortality, and healthcare costs.
World Health Organisation (WHO) has declared that AMR is one of the top 10 global public health threats facing humanity. The COVID-19 pandemic has highlighted the importance of AMR as it has led to increased use of antimicrobial drugs, particularly antibiotics, which can contribute to the development of AMR. People with COVID-19 may develop secondary bacterial infections, such as pneumonia, and may be prescribed antibiotics to treat these infections. However, unnecessary use of antibiotics can lead to the emergence and spread of resistant bacteria, making it more difficult to treat infections in the future.

Coordinator

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Net EU contribution
€ 92 000,00
Address
VIA ZAMBONI 33
40126 Bologna
Italy

See on map

Region
Nord-Est Emilia-Romagna Bologna
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (3)

Partners (4)